Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220687637> ?p ?o ?g. }
- W4220687637 endingPage "1151" @default.
- W4220687637 startingPage "1127" @default.
- W4220687637 abstract "Parkinson disease (PD) is a neurodegenerative disorder characterized by the abnormal intracellular accumulation of SNCA/α-synuclein. While the exact mechanisms underlying SNCA pathology are not fully understood, increasing evidence suggests the involvement of autophagy as well as lysosomal deficiencies. Because CTSD (cathepsin D) has been proposed to be the major lysosomal protease involved in SNCA degradation, its deficiency has been linked to the presence of insoluble SNCA conformers in the brain of mice and humans as well as to the transcellular transmission of SNCA aggregates. We here postulate that SNCA degradation can be enhanced by the application of the recombinant human proform of CTSD (rHsCTSD). Our results reveal that rHsCTSD is efficiently endocytosed by neuronal cells, correctly targeted to lysosomes and matured to an enzymatically active protease. In dopaminergic neurons derived from induced pluripotent stem cells (iPSC) of PD patients harboring the A53T mutation within the SNCA gene, we confirm the reduction of insoluble SNCA after treatment with rHsCTSD. Moreover, we demonstrate a decrease of pathological SNCA conformers in the brain and within primary neurons of a ctsd-deficient mouse model after dosing with rHsCTSD. Boosting lysosomal CTSD activity not only enhanced SNCA clearance in human and murine neurons as well as tissue, but also restored endo-lysosome and autophagy function. Our findings indicate that CTSD is critical for SNCA clearance and function. Thus, enzyme replacement strategies utilizing CTSD may also be of therapeutic interest for the treatment of PD and other synucleinopathies aiming to decrease the SNCA burden.Abbreviations: aa: amino acid; SNCA/α-synuclein: synuclein alpha; APP: amyloid beta precursor protein; BBB: blood brain barrier; BF: basal forebrain; CBB: Coomassie Brilliant Blue; CLN: neuronal ceroid lipofuscinosis; CNL10: neuronal ceroid lipofuscinosis type 10; Corr.: corrected; CTSD: cathepsin D; CTSB: cathepsin B; DA: dopaminergic; DA-iPSn: induced pluripotent stem cell-derived dopaminergic neurons; dox: doxycycline; ERT: enzyme replacement therapy; Fx: fornix, GBA/β-glucocerebrosidase: glucosylceramidase beta; h: hour; HC: hippocampus; HT: hypothalamus; i.c.: intracranially; IF: immunofluorescence; iPSC: induced pluripotent stem cell; KO: knockout; LAMP1: lysosomal associated membrane protein 1; LSDs: lysosomal storage disorders; MAPT: microtubule associated protein tau; M6P: mannose-6-phosphate; M6PR: mannose-6-phosphate receptor; MB: midbrain; mCTSD: mature form of CTSD; neurofil.: neurofilament; PD: Parkinson disease; proCTSD: proform of CTSD; PRNP: prion protein; RFU: relative fluorescence units; rHsCTSD: recombinant human proCTSD; SAPC: Saposin C; SIM: structured illumination microscopy; T-insol: Triton-insoluble; T-sol: Triton-soluble; TEM: transmission electron microscopy, TH: tyrosine hydroxylase; Thal: thalamus." @default.
- W4220687637 created "2022-04-03" @default.
- W4220687637 creator A5002539597 @default.
- W4220687637 creator A5003394753 @default.
- W4220687637 creator A5015979775 @default.
- W4220687637 creator A5022369744 @default.
- W4220687637 creator A5022416494 @default.
- W4220687637 creator A5029896435 @default.
- W4220687637 creator A5032467961 @default.
- W4220687637 creator A5045195033 @default.
- W4220687637 creator A5046203546 @default.
- W4220687637 creator A5046629505 @default.
- W4220687637 creator A5050301636 @default.
- W4220687637 creator A5057474437 @default.
- W4220687637 creator A5057570590 @default.
- W4220687637 creator A5057748854 @default.
- W4220687637 creator A5061611026 @default.
- W4220687637 creator A5062223062 @default.
- W4220687637 creator A5063850784 @default.
- W4220687637 creator A5066726616 @default.
- W4220687637 creator A5073944069 @default.
- W4220687637 creator A5080558971 @default.
- W4220687637 creator A5081757237 @default.
- W4220687637 creator A5087994825 @default.
- W4220687637 creator A5091097382 @default.
- W4220687637 date "2022-04-28" @default.
- W4220687637 modified "2023-10-18" @default.
- W4220687637 title "Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models" @default.
- W4220687637 cites W1483408272 @default.
- W4220687637 cites W1560487523 @default.
- W4220687637 cites W1572679174 @default.
- W4220687637 cites W1790444722 @default.
- W4220687637 cites W1860081569 @default.
- W4220687637 cites W1907174433 @default.
- W4220687637 cites W192269116 @default.
- W4220687637 cites W1964331882 @default.
- W4220687637 cites W1967339034 @default.
- W4220687637 cites W1971075885 @default.
- W4220687637 cites W1972818453 @default.
- W4220687637 cites W1973738022 @default.
- W4220687637 cites W1975396085 @default.
- W4220687637 cites W1981153918 @default.
- W4220687637 cites W1983790532 @default.
- W4220687637 cites W1984304206 @default.
- W4220687637 cites W1986518444 @default.
- W4220687637 cites W1986625112 @default.
- W4220687637 cites W1986656413 @default.
- W4220687637 cites W1991366673 @default.
- W4220687637 cites W2009573330 @default.
- W4220687637 cites W2022649483 @default.
- W4220687637 cites W2026175550 @default.
- W4220687637 cites W2027649342 @default.
- W4220687637 cites W2029660291 @default.
- W4220687637 cites W2031365272 @default.
- W4220687637 cites W2037088901 @default.
- W4220687637 cites W2040454459 @default.
- W4220687637 cites W2043835731 @default.
- W4220687637 cites W2055897605 @default.
- W4220687637 cites W2056516960 @default.
- W4220687637 cites W2056979920 @default.
- W4220687637 cites W2060102282 @default.
- W4220687637 cites W2060112329 @default.
- W4220687637 cites W2065378127 @default.
- W4220687637 cites W2067854525 @default.
- W4220687637 cites W2068192505 @default.
- W4220687637 cites W2068288454 @default.
- W4220687637 cites W2069274491 @default.
- W4220687637 cites W2074938894 @default.
- W4220687637 cites W2076107153 @default.
- W4220687637 cites W2076533476 @default.
- W4220687637 cites W2077980390 @default.
- W4220687637 cites W2084107843 @default.
- W4220687637 cites W2092339616 @default.
- W4220687637 cites W2095351157 @default.
- W4220687637 cites W2095706874 @default.
- W4220687637 cites W2097048253 @default.
- W4220687637 cites W2103377481 @default.
- W4220687637 cites W2103894947 @default.
- W4220687637 cites W2108920393 @default.
- W4220687637 cites W2119307218 @default.
- W4220687637 cites W2121981334 @default.
- W4220687637 cites W2123431154 @default.
- W4220687637 cites W2127342428 @default.
- W4220687637 cites W2129345131 @default.
- W4220687637 cites W2130128490 @default.
- W4220687637 cites W2130361709 @default.
- W4220687637 cites W2130898002 @default.
- W4220687637 cites W2139369185 @default.
- W4220687637 cites W2141459724 @default.
- W4220687637 cites W2142291517 @default.
- W4220687637 cites W2145396101 @default.
- W4220687637 cites W2147798737 @default.
- W4220687637 cites W2150656456 @default.
- W4220687637 cites W2154679217 @default.
- W4220687637 cites W2154737306 @default.
- W4220687637 cites W2155738133 @default.
- W4220687637 cites W2156370322 @default.
- W4220687637 cites W2156561885 @default.